This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Djelouagji, Z.
Right arrow Articles by Drancourt, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Djelouagji, Z.
Right arrow Articles by Drancourt, M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2006, p. 1594-1595, Vol. 44, No. 4
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.4.1594-1595.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Inactivation of Cultured Mycobacterium tuberculosis Organisms Prior to DNA Extraction


arrow
LETTER
 
Somerville and his colleagues have made an important point that current protocols for DNA extraction from cultured Mycobacterium tuberculosis organisms do not ensure complete inactivation of the microorganism (9). While diagnosis samples of tuberculosis can be manipulated under biosafety level 2 (BSL2) conditions, live cultured M. tuberculosis organisms have to be manipulated under BSL3 conditions. Accordingly, M. tuberculosis organisms have to be inactivated prior to release outside a BSL3 laboratory for further molecular biology manipulation, for example. Indeed, M. tuberculosis poses potential risks for the laboratory personnel working with this microorganism (6). There are several reports of laboratory-acquired tuberculosis infections, with aerosols and skin punctures being the most common reported routes of transmission (8). This emphasizes the need for complete inactivation of M. tuberculosis before extraction of DNA from this microorganism. We surveyed the 2004 issues of the Journal of Clinical Microbiology for published reports addressing this issue. To our surprise, in only 6 of a total of 64 reports that we surveyed were cultured M. tuberculosis organisms inactivated before DNA was extracted from them. This prompted us to evaluate a simple protocol for the inactivation of and DNA extraction from cultured M. tuberculosis. Discussed herein are 10 isolates of mycobacterium belonging to the M. tuberculosis complex. Their identities were based on a 16S rRNA gene probing assay (BioMérieux, Marcy l'Etoile, France). The identification of species within the complex was based on the resistance of the isolates to pyrazinamide in order to distinguish M. tuberculosis from Mycobacterium bovis (5). The mycobacterial isolates had been stored at –20°C by freezing the beads on which they were placed (Dominique Dutscher, Brumath, France) before they were used. For inactivation, one bead was held (about 2 h) in 100 µl of 90% ethanol (Carlo Erba Réactifs SA, Val de Reuil, France) at room temperature until complete evaporation of the ethanol was achieved before the organisms were incubated at 96°C in 20% Chelex for an hour (2). The efficacy of the inactivation procedure was assessed by inoculating BACTEC9000 MB broth (BD Diagnostic Systems, Le Pont de Claix, France) with the bead according to the manufacturer's instructions and, in parallel, scraping the bead onto 5% sheep blood agar at 37°C (4). As a positive control, a bead of the same isolate not inactivated as described above (i.e., the noninactivated bead) was cultured in parallel under the same conditions. After 3 weeks of incubation, M. tuberculosis was cultured in broth and blood agar from only the noninactivated beads, not the beads that had been inactivated (10 of 10 versus 0 of 10 tested; P < 0.0001 by the chi-square test with Yates' correction). Furthermore, the supernatant was subjected to PCR for the amplification of the rpoB gene (7) and hybridization using 16S rRNA probes (GenProbe, San Diego, CA). A positive amplicon was obtained with all 10 isolates tested, and sequencing was easily performed in every case. Like-wise, all DNA extracts yielded positive hybridization with the 16S rRNA gene-derived probe. These data show that the inactivation-extraction protocol that we evaluated was suitable for providing M. tuberculosis DNA for hybridization and PCR-based experiments. This protocol may be helpful since the issue of M. tuberculosis organisms' inactivation remains problematic, as no protocol until now had proved effective. Heating the microorganism at 80°C is the most popular protocol according to favorable evaluations in several reports (1, 3). However, the reproducible effectiveness of this simple protocol remains controversial (10). Likewise, further incubation in the presence of proteinase K and lysozyme failed to inactivate M. tuberculosis (1). Somerville and collaborators found that as many as 77.1% of 35 M. tuberculosis isolates heated at 80°C remained viable, despite further chemical treatments (9). The protocol presented herein takes 3 h, uses nontoxic substances, and requires only basic laboratory equipment, thus offering a convenient way to effectively inactivate M. tuberculosis prior to PCR amplification and hybridization. Assessment of DNA suitability for other molecular biology works, such as restriction profiling, warrants further studies. We are using this protocol routinely for the inactivation of M. tuberculosis isolates before their release from a level 3 containment facility for further molecular workup.

We recommend the inactivation of M. tuberculosis before extraction of DNA from it, and for this, we propose a cheap, rapid, and efficient method.


arrow
REFERENCES
 
    1
  1. Bemer-Melchior, P., and H. B. Drugeon. 1999. Inactivation of Mycobacterium tuberculosis for DNA typing analysis. J. Clin. Microbiol. 37:2350-2351.[Abstract/Free Full Text]
    2. 2
  2. de Lamballerie, X., C. Zandotti, C. Vignoli, C. Bollet, and P. de Micco. 1992. A one-step microbial DNA extraction method using "Chelex 100" suitable for gene amplification. Res. Microbiol. 143:785-790.[Medline]
    3. 3
  3. Doig, C., A. L. Seagar, B. Watt, and K. J. Forbes. 1992. The efficacy of the heat killing of Mycobacterium tuberculosis. J. Clin. Pathol. 55:778-779.
    4. 4
  4. Drancourt, M., P. Carrieri, M. J. Gevaudan, and D. Raoult. 2003. Blood agar and Mycobacterium tuberculosis: the end of a dogma. J. Clin. Microbiol. 41:1710-1711.[Abstract/Free Full Text]
    5. 5
  5. Inderlied, C. B., and G. E. Pfyffer. 2003. Susceptibility test methods: mycobacteria, p. 1149-1177. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. ASM Press, Washington, D.C.
    6. 6
  6. Kao, A. S., D. A. Ashford, M. M. McNeil, N. G. Warren, and R. C. Good. 1997. Descriptive profile of tuberculin skin testing programs and laboratory-acquired tuberculosis infections in public health laboratories. J. Clin. Microbiol. 35:1847-1851.[Abstract]
    7. 7
  7. Kim, B. J., S. H. Lee, M. A. Lyu, S. J. Kim, G. H. Bai, G. T. Chae, E. C. Kim, C. Y. Cha, and Y. H. Kook. 1999. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J. Clin. Microbiol. 37:1714-1720.[Abstract/Free Full Text]
    8. 8
  8. Menzies, D., A. Fanning, L. Yuan, and M. Fitzgerald. 1995. Tuberculosis among health care workers. N. Engl. J. Med. 332:92-98.[Free Full Text]
    9. 9
  9. Somerville, W., L. Thibert, K. Schwartzman, and M. A. Behr. 2005. Extraction of Mycobacterium tuberculosis DNA: a question of containment. J. Clin. Microbiol. 43:2996-2997.[Abstract/Free Full Text]
    10. 10
  10. Zwadyk, P., Jr., J. A. Down, N. Myers, and M. S. Dey. 1994. Rendering of mycobacteria safe for molecular diagnostic studies and development of a lysis method for strand displacement amplification and PCR. J. Clin. Microbiol. 32:2140-2146.[Abstract/Free Full Text]
Zoheira Djelouagji
Michel Drancourt*
Unité des Rickettsies
Faculté de Médecine
27 Boulevard Jean Moulin
13385 Marseille Cedex 5
France

* Phone: 00 33 4 91 38 55 17, Fax: 00 33 4 91 38 77 72, E-mail: Michel.Drancourt{at}medecine.univ-mrs.fr

Journal of Clinical Microbiology, April 2006, p. 1594-1595, Vol. 44, No. 4
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.4.1594-1595.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Ben Salah, I., Adekambi, T., Raoult, D., Drancourt, M. (2008). rpoB sequence-based identification of Mycobacterium avium complex species. Microbiology 154: 3715-3723 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Djelouagji, Z.
Right arrow Articles by Drancourt, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Djelouagji, Z.
Right arrow Articles by Drancourt, M.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»